Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
Angela Duvalyan, Ambarish Pandey, Muthiah Vaduganathan, Utibe R. Essien, Ethan A. Halm, Gregg C. Fonarow, Andrew Sumarsono
Abstract
ince the introduction of direct oral anticoagulants (DOACs), multiple large studies have demonstrated that DOACs are more effective, have fewer bleeding risks, and require less monitoring when compared with warfarin. 1 Given the rising use of DOACs, the many anticoagulation indications that require lifelong therapy and the current lack of generic DOAC formulations, we examine contemporary DOAC spending patterns within Medicare Part D and Medicaid between 2014 and 2019.
Topics & Concepts
MedicaidMedicineMedicare Part DMedical prescriptionFamily medicineCenter (category theory)GerontologyLibrary sciencePrescription drugLawPolitical scienceNursingHealth careCrystallographyChemistryComputer scienceAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementBlood Pressure and Hypertension Studies